These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 24865415)
1. Kinetic study of the binding of triplex-forming oligonucleotides containing partial cationic modifications to double-stranded DNA. Hari Y; Ijitsu S; Akabane-Nakata M; Yoshida T; Obika S Bioorg Med Chem Lett; 2014 Jul; 24(14):3046-9. PubMed ID: 24865415 [TBL] [Abstract][Full Text] [Related]
9. Recognition of RNA duplexes by chemically modified triplex-forming oligonucleotides. Zhou Y; Kierzek E; Loo ZP; Antonio M; Yau YH; Chuah YW; Geifman-Shochat S; Kierzek R; Chen G Nucleic Acids Res; 2013 Jul; 41(13):6664-73. PubMed ID: 23658228 [TBL] [Abstract][Full Text] [Related]
10. Fluorescent intercalator displacement replacement (FIDR) assay: determination of relative thermodynamic and kinetic parameters in triplex formation--a case study using triplex-forming LNAs. Sau SP; Kumar P; Sharma PK; Hrdlicka PJ Nucleic Acids Res; 2012 Nov; 40(21):e162. PubMed ID: 22855561 [TBL] [Abstract][Full Text] [Related]
11. Metal-responsive reversible binding of triplex-forming oligonucleotides with 5-hydroxyuracil nucleobases. Nishiyama K; Mori K; Takezawa Y; Shionoya M Chem Commun (Camb); 2021 Mar; 57(20):2487-2490. PubMed ID: 33616595 [TBL] [Abstract][Full Text] [Related]
12. A new approach to overcome potassium-mediated inhibition of triplex formation. Svinarchuk F; Cherny D; Debin A; Delain E; Malvy C Nucleic Acids Res; 1996 Oct; 24(19):3858-65. PubMed ID: 8871568 [TBL] [Abstract][Full Text] [Related]
13. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment. Brunet E; Corgnali M; Cannata F; Perrouault L; Giovannangeli C Nucleic Acids Res; 2006; 34(16):4546-53. PubMed ID: 16951289 [TBL] [Abstract][Full Text] [Related]
14. Stable and Selective Antiparallel Type Triplex DNA Formation by Targeting a GC Base Pair with the TFO Containing One N Taniguchi Y; Miyazaki M; Matsueda N; Wang L; Okamura H; Sasaki S Chem Pharm Bull (Tokyo); 2018; 66(6):624-631. PubMed ID: 29863064 [TBL] [Abstract][Full Text] [Related]
15. Promotion of stable triplex formation by partial incorporation of 2',5'-phosphodiester linkages into triplex-forming oligonucleotides. Obika S; Hiroto A; Nakagawa O; Imanishi T Chem Commun (Camb); 2005 Jun; (22):2793-5. PubMed ID: 15928760 [TBL] [Abstract][Full Text] [Related]
17. Targeting DNA with "light-up" pyrimidine triple-helical forming oligonucleotides conjugated to stabilizing fluorophores (LU-TFOs). Renard BL; Lartia R; Asseline U Org Biomol Chem; 2008 Dec; 6(23):4413-25. PubMed ID: 19005602 [TBL] [Abstract][Full Text] [Related]
18. Site-directed inhibition of DNA replication by triple helix formation. Diviacco S; Rapozzi V; Xodo L; Helene C; Quadrifoglio F; Giovannangeli C FASEB J; 2001 Dec; 15(14):2660-8. PubMed ID: 11726542 [TBL] [Abstract][Full Text] [Related]
19. Triplex staples: DNA double-strand cross-linking at internal and terminal sites using psoralen-containing triplex-forming oligonucleotides. Li H; Broughton-Head VJ; Peng G; Powers VE; Ovens MJ; Fox KR; Brown T Bioconjug Chem; 2006; 17(6):1561-7. PubMed ID: 17105237 [TBL] [Abstract][Full Text] [Related]
20. Antigene-block strategy: effective regulation of gene expression by 2',4'-BNA-modified TFOs with an additional stem-loop structure. Tsuda N; Matsumoto A; Ito A; Uneda T; Tanabe A; Obika S; Imanishi T Nucleic Acids Symp Ser (Oxf); 2005; (49):335-6. PubMed ID: 17150770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]